KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $17.0 million.

  • Moderna's Amortizatization of Intangibles fell 1904.76% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.0 million, marking a year-over-year decrease of 2395.83%. This contributed to the annual value of $95.0 million for FY2024, which is 5573.77% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Amortizatization of Intangibles is $17.0 million, which was down 1904.76% from $18.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Amortizatization of Intangibles ranged from a high of $28.0 million in Q2 2024 and a low of -$21.0 million during Q4 2021
  • For the 5-year period, Moderna's Amortizatization of Intangibles averaged around $6.6 million, with its median value being $12.0 million (2023).
  • In the last 5 years, Moderna's Amortizatization of Intangibles crashed by 70000.0% in 2021 and then surged by 40000.0% in 2023.
  • Moderna's Amortizatization of Intangibles (Quarter) stood at -$21.0 million in 2021, then surged by 119.05% to $4.0 million in 2022, then surged by 400.0% to $20.0 million in 2023, then fell by 5.0% to $19.0 million in 2024, then dropped by 10.53% to $17.0 million in 2025.
  • Its last three reported values are $17.0 million in Q3 2025, $18.0 million for Q2 2025, and $19.0 million during Q1 2025.